US Patent 8262728 Intra-ocular device with multiple focusing powers/optics
Patent 8262728 was granted and assigned to Novartis on September, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08262728 Intra-ocular device with multiple focusing powers/optics US Patent 8262728 Intra-ocular device with multiple focusing powers/optics
Infobox
Patent Number
0826272800
Patent Number
826272800
Edits on 25 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082627280
Date of Patent
September 11, 2012
0Patent Application Number
127768070
Date Filed
May 10, 2010
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082627280
Date of Patent
September 11, 2012
0Patent Application Number
127768070
Date Filed
May 10, 2010
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08262728 Intra-ocular device with multiple focusing powers/optics
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08262728
Date of patent
September 11, 2012
Patent application number
12776807
Date Filed
May 10, 2010
Patent primary examiner
Find more entities like US Patent 8262728 Intra-ocular device with multiple focusing powers/optics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.